|Articles|July 27, 2022
Medidata Supports White House Cancer Moonshot Effort
Cancer Moonshot Biobank relies on Medidata's eConsent and EDC platforms.
Advertisement
Medidata is supporting the White House Cancer Moonshot initiative by working with the National Cancer Institute (NCI) to enroll patients in the Cancer Moonshot Biobank.
The Cancer Moonshot Biobank relies on Medidata’s Patient Cloud and Rave solutions, including eConsent and Rave EDC (electronic data capture).
Read more about Medidata's involvement
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Advarra and IgniteData Partner to Streamline eSource-to-EDC Data Transfer
2
Improving Site Satisfaction Through Better Technology and Collaboration
3
Gilead’s Single-Tablet Bictegravi/Lenacapavir Regimen Shows Positive Phase III ARTISTRY-1 Results in Virologically Suppressed Adults with HIV
4
Modernizing Recruitment with Data, HCP Networks, and Last Mile Support
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
